{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:16:03Z","timestamp":1792034163886,"version":"4.4.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011960","name":"Debra International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.addr.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T22:30:35Z","timestamp":1513290635000},"page":"330-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Functional therapies for cutaneous wound repair in epidermolysis bullosa"],"prefix":"10.1016","volume":"129","author":[{"given":"Patricia","family":"Peking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2017.12.003_bb0005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jid.2017.01.004","article-title":"Mutations in KLHL24 add to the molecular heterogeneity of epidermolysis bullosa simplex","volume":"137","author":"Lee","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5021\/ad.2015.27.6.658","article-title":"Recently identified forms of epidermolysis bullosa","volume":"27","author":"McGrath","year":"2015","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-genom-090413-025540","article-title":"The genetics of skin fragility","volume":"15","author":"Has","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1067\/mjd.2000.106369","article-title":"Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolysis bullosa","volume":"42","author":"Fine","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/000155501750376285","article-title":"Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa","volume":"81","author":"Weber","year":"2001","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.addr.2017.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/jid.2013.137","article-title":"Systemic protein therapy for recessive dystrophic epidermolysis bullosa: how far are we from clinical translation?","volume":"133","author":"Hovnanian","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","article-title":"Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa","volume":"10","author":"Woodley","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0045","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0050","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0055","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2017.12.003_bb0070","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0085","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2017.12.003_bb0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ceb.2003.10.011","article-title":"The multifaceted adult epidermal stem cell","volume":"15","author":"Gambardella","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.addr.2017.12.003_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cell.2007.01.014","article-title":"Epithelial stem cells: turning over new leaves","volume":"128","author":"Blanpain","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.addr.2017.12.003_bb0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/jid.2011.450","article-title":"Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath","volume":"132","author":"Coulombe","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0105","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI38177","article-title":"Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility","volume":"119","author":"Coulombe","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2017.12.003_bb0110","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1093\/hmg\/ddq405","article-title":"K14 mRNA reprogramming for dominant epidermolysis bullosa simplex","volume":"19","author":"Wally","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2010.01.001","article-title":"Epidermolysis bullosa simplex with muscular dystrophy","volume":"28","author":"Chiaverini","year":"2010","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.addr.2017.12.003_bb0120","first-page":"849","article-title":"Junctional epidermolysis bullosa with LAMB3 splice-site mutations","volume":"95","author":"Kiritsi","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.addr.2017.12.003_bb0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cam.22418","article-title":"Laminin 332 in junctional epidermolysis bullosa","volume":"7","author":"Kiritsi","year":"2013","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.addr.2017.12.003_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2230.2003.01192.x","article-title":"Type XVII collagen gene mutations in junctional epidermolysis bullosa and prospects for gene therapy","volume":"28","author":"Bauer","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0135","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2340\/00015555-0484","volume":"88","author":"Dang","year":"2008","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.addr.2017.12.003_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.jp.7211019","article-title":"Dystrophic epidermolysis bullosa","volume":"24","author":"Das","year":"2004","journal-title":"J. Perinatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/CCID.S54681","article-title":"Dystrophic epidermolysis bullosa: a review","volume":"8","author":"Shinkuma","year":"2015","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0150","first-page":"671","article-title":"Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance","volume":"58","author":"Christiano","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-5-12","article-title":"Inherited epidermolysis bullosa","volume":"5","author":"Fine","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.addr.2017.12.003_bb0160","first-page":"41","article-title":"Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies","volume":"8","author":"Soro","year":"2015","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0165","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","article-title":"Innate sensing of microbial products promotes wound-induced skin cancer","volume":"6","author":"Hoste","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2017.12.003_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","article-title":"Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development","volume":"63","author":"Guerra","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.addr.2017.12.003_bb0175","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0180","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.2353\/ajpath.2009.090203","article-title":"Kindlin-1 Is required for RhoGTPase-mediated lamellipodia formation in keratinocytes","volume":"175","author":"Has","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2017.12.003_bb0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4103\/0378-6323.16788","article-title":"Kindler syndrome","volume":"71","author":"Kaviarasan","year":"2005","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.addr.2017.12.003_bb0190","first-page":"2172","article-title":"Functional differences between Kindlin-1 and Kindlin-2 in keratinocytes","volume":"125","author":"Bandyopadhyay","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2017.12.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000289","article-title":"Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction","volume":"4","author":"Ussar","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2133.2009.09243.x","article-title":"Gene therapy of inherited skin adhesion disorders: a critical overview","volume":"161","author":"De Luca","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0205","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/dev.104588","article-title":"Heterogeneity and plasticity of epidermal stem cells","volume":"141","author":"Schepeler","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.addr.2017.12.003_bb0210","first-page":"75","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2017.12.003_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/17460751.1.1.45","article-title":"Regeneration of squamous epithelia from stem cells of cultured grafts","volume":"1","author":"De Luca","year":"2006","journal-title":"Regen. Med."},{"issue":"7680","key":"10.1016\/j.addr.2017.12.003_bb4000","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2017.12.003_bb0220","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.12.003_bb0230","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.12.003_bb0235","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/JVI.00011-14","article-title":"Enhancers are major targets for murine leukemia virus vector integration","volume":"88","author":"De Ravin","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2017.12.003_bb0240","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.1083413","article-title":"Transcription start regions in the human genome are favored targets for MLV integration","volume":"300","author":"Wu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.12.003_bb0245","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1093\/nar\/gkt1399","article-title":"MLV integration site selection is driven by strong enhancers and active promoters","volume":"42","author":"LaFave","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.12.003_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stemcr.2013.11.001","article-title":"Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa","volume":"2","author":"DeRosa","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2017.12.003_bb0260","doi-asserted-by":"crossref","first-page":"24429","DOI":"10.1074\/jbc.M003440200","article-title":"Development and characterization of a recombinant truncated type VII collagen \u201cminigene\u201d. Implication for gene therapy of dystrophic epidermolysis bullosa","volume":"275","author":"Chen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2017.12.003_bb0265","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/jid.2011.172","article-title":"Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts","volume":"131","author":"Gache","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0270","doi-asserted-by":"crossref","first-page":"41336","DOI":"10.1074\/jbc.M103139200","article-title":"Gene correction of integrin beta4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for beta4 tyrosines 1422 and 1440 in hemidesmosome assembly","volume":"276","author":"Dellambra","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2017.12.003_bb0275","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/hum.2010.023","article-title":"Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue","volume":"21","author":"Siprashvili","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.12.003_bb0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.addr.2017.12.003_bb0290","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/sj.gt.3302807","article-title":"Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors","volume":"13","author":"Schambach","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0295","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng1041","article-title":"Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa","volume":"32","author":"Chen","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0300","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0305","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0310","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0315","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jid.2016.02.811","article-title":"Gene-corrected fibroblast therapy for recessive dystrophic epidermolysis bullosa using a self-inactivating COL7A1 retroviral vector","volume":"136","author":"Jackow","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/JID.2015.364","article-title":"Lentiviral engineered fibroblasts expressing codon-optimized COL7A1 restore anchoring fibrils in RDEB","volume":"136","author":"Georgiadis","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0325","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/mt.2008.204","article-title":"Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors","volume":"16","author":"Di Nunzio","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0330","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/mt.2014.14","article-title":"Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy","volume":"22","author":"Sallach","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.19","article-title":"gene editing for the efficient correction of a recurrent COL7A1 mutation in recessive dystrophic epidermolysis bullosa keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2017.12.003_bb0340","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nprot.2011.301","article-title":"AAV-mediated gene targeting methods for human cells","volume":"6","author":"Khan","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2017.12.003_bb0345","doi-asserted-by":"crossref","first-page":"a015149","DOI":"10.1101\/cshperspect.a015149","article-title":"Gene therapy for skin diseases","volume":"4","author":"Gorell","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0350","article-title":"Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders","author":"March","year":"2017","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.addr.2017.12.003_bb0355","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo","volume":"8","author":"Chen","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.3","article-title":"A gene gun-mediated nonviral RNA trans-splicing strategy for Col7a1 repair","volume":"5","author":"Peking","year":"2016","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2017.12.003_bb0365","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.12.003_bb0370","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.addr.2017.12.003_bb0375","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ad.2015.01.007","article-title":"Innovative therapeutic strategies for recessive dystrophic epidermolysis bullosa","volume":"106","author":"Larcher","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.addr.2017.12.003_bb0380","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.87","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2017.12.003_bb0390","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0395","first-page":"369","article-title":"Microneedle-based vaccines","volume":"333","author":"Prausnitz","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2017.12.003_bb0400","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/AJP.0b013e318225dbe9","article-title":"Rapid local anesthesia in humans using minimally invasive microneedles","volume":"28","author":"Gupta","year":"2012","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.addr.2017.12.003_bb0405","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2008.0103","article-title":"Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles","volume":"11","author":"Gupta","year":"2009","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0410","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/dia.2010.0204","article-title":"Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects","volume":"13","author":"Gupta","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0415","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/srep00158","article-title":"Visualization of plasmid delivery to keratinocytes in mouse and human epidermis","volume":"1","author":"Gonzalez-Gonzalez","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2017.12.003_bb0420","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/mt.2010.126","article-title":"Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD)","volume":"18","author":"Gonzalez-Gonzalez","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0425","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2017.02.028","article-title":"Hydrodynamic gene delivery in human skin using a hollow microneedle device","volume":"265","author":"Dul","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2017.12.003_bb0430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0435","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-3054.1990.tb05888.x","article-title":"Biolistic plant transformation","volume":"79","author":"Sanford","year":"1990","journal-title":"Physiol. Plant."},{"key":"10.1016\/j.addr.2017.12.003_bb0440","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/jid.2012.19","article-title":"Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance","volume":"132","author":"Ettinger","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102280","article-title":"Structural integrity of the antigen is a determinant for the induction of T-helper type-1 immunity in mice by gene gun vaccines against E. coli beta-galactosidase","volume":"9","author":"Deressa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2017.12.003_bb0450","doi-asserted-by":"crossref","first-page":"9568","DOI":"10.1073\/pnas.87.24.9568","article-title":"In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment","volume":"87","author":"Yang","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.12.003_bb0455","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/bbrc.2000.2369","article-title":"In vivo gene gun-mediated DNA delivery into rodent brain tissue","volume":"270","author":"Sato","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2017.12.003_bb0460","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.gt.3301404","article-title":"Direct transfection and activation of human cutaneous dendritic cells","volume":"8","author":"Larregina","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0465","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/ijms14011629","article-title":"Biopolymer-based nanoparticles for drug\/gene delivery and tissue engineering","volume":"14","author":"Nitta","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2017.12.003_bb0470","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.addr.2011.01.012","article-title":"Nanoparticles and microparticles for skin drug delivery","volume":"63","author":"Prow","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2017.12.003_bb0475","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/2229-5178.120635","article-title":"Nanocarriers and nanoparticles for skin care and dermatological treatments","volume":"4","author":"Gupta","year":"2013","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.addr.2017.12.003_bb0480","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/exd.13054","article-title":"A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa","volume":"25","author":"Cutlar","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0485","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2302\/kjm.2014-0013-RE","article-title":"Advances in gene\/cell therapy in epidermolysis bullosa","volume":"64","author":"Murauer","year":"2015","journal-title":"Keio J. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0490","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/mt.2016.199","article-title":"Gene therapy for epidermolysis bullosa: sticky business","volume":"24","author":"Nystrom","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.trsl.2015.05.008","article-title":"Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa","volume":"168","author":"Perdoni","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0500","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/mt.2014.187","article-title":"Long-term skin regeneration from a gene-targeted human epidermal stem cell clone","volume":"22","author":"Duarte","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0505","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.mt.6300238","article-title":"Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy","volume":"15","author":"Larcher","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0510","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.0800940105","article-title":"Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases","volume":"105","author":"Santiago","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.12.003_bb0515","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.omtm.2017.06.008","article-title":"Traceless targeting and isolation of gene edited immortalised keratinocytes from epidermolysis bullosa simplex patients","volume":"6","author":"Aushev","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.addr.2017.12.003_bb0520","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0525","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1093\/nar\/gkt754","article-title":"Directed evolution of the TALE N-terminal domain for recognition of all 5\u2032 bases","volume":"41","author":"Lamb","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0530","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2350-11-139","article-title":"A prevalent mutation with founder effect in Spanish recessive dystrophic epidermolysis bullosa families","volume":"11","author":"Cuadrado-Corrales","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.addr.2017.12.003_bb0535","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2017.12.003_bb0540","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.12.003_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/npjregenmed.2016.14","article-title":"CRISPR\/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa","volume":"1","author":"Webber","year":"2016","journal-title":"NPJ Regen. Med."},{"issue":"11","key":"10.1016\/j.addr.2017.12.003_bb0550","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0555","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.1614775114","article-title":"Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.12.003_bb0560","first-page":"974","article-title":"The molecular mechanism of CRISPR\/Cas9 system and its application in gene therapy of human diseases","volume":"37","author":"Liang","year":"2015","journal-title":"Yi Chuan"},{"key":"10.1016\/j.addr.2017.12.003_bb0565","first-page":"1003","article-title":"Progress of application and off-target effects of CRISPR\/Cas9","volume":"37","author":"Wu","year":"2015","journal-title":"Yi Chuan"},{"key":"10.1016\/j.addr.2017.12.003_bb0570","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells","volume":"2","author":"Jinek","year":"2013","journal-title":"elife"},{"key":"10.1016\/j.addr.2017.12.003_bb0575","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.addr.2017.12.003_bb0580","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-4632.2010.04702.x","article-title":"Missense mutation at the helix termination region in the 2B domain of keratin 14 in a Japanese family with epidermolysis bullosa simplex, generalized, other","volume":"50","author":"Kaneko","year":"2011","journal-title":"Int. J. Dermatol."},{"issue":"11","key":"10.1016\/j.addr.2017.12.003_bb0585","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and paste: efficient homology-directed repair of a dominant negative KRT14 mutation via CRISPR\/Cas9 nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0590","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/exd.13141","article-title":"RNA-based therapies for genodermatoses","volume":"26","author":"Bornert","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0595","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-767-5_15","article-title":"Antisense-mediated exon skipping to reframe transcripts","volume":"867","author":"Turczynski","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.addr.2017.12.003_bb0600","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0605","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jid.2012.101","article-title":"Spliceosome-mediated trans-splicing: the therapeutic cut and paste","volume":"132","author":"Wally","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0610","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/gt.2016.57","article-title":"Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations","volume":"23","author":"Tockner","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0615","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.jid.5701152","article-title":"5\u2032 trans-splicing repair of the PLEC1 gene","volume":"128","author":"Wally","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0620","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.1093\/nar\/gkx669","article-title":"An RNA-targeted therapy for dystrophic epidermolysis bullosa","volume":"45","author":"Peking","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2017.12.003_bb0625","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/humu.21551","article-title":"The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations","volume":"32","author":"van den Akker","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.addr.2017.12.003_bb0630","series-title":"DEB Register","author":"Van den Akker","year":"2015"},{"key":"10.1016\/j.addr.2017.12.003_bb0635","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.addr.2017.12.003_bb0640","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","article-title":"Pharmaceutical therapies to recode nonsense mutations in inherited diseases","volume":"136","author":"Lee","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.addr.2017.12.003_bb0645","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/mt.2014.140","article-title":"Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa","volume":"22","author":"Cogan","year":"2014","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.addr.2017.12.003_bb0650","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jid.2017.05.011","article-title":"Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive dystrophic epidermolysis bullosa","volume":"137","author":"Atanasova","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0655","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2017.12.003_bb0660","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","article-title":"Ataluren as an agent for therapeutic nonsense suppression","volume":"64","author":"Peltz","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081302","article-title":"Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy","volume":"8","author":"Finkel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2017.12.003_bb0670","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2017.12.003_bb0675","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/jid.2011.169","article-title":"Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex","volume":"131","author":"Atkinson","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0680","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/jid.2012.11","article-title":"siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa","volume":"132","author":"Pendaries","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0685","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1038\/jid.2013.241","article-title":"A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa","volume":"133","author":"Morgan","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0690","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molmed.2010.11.003","article-title":"Revertant mosaicism in skin: natural gene therapy","volume":"17","author":"Lai-Cheong","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0695","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc0809896","article-title":"Revertant mosaicism\u2013patchwork in the skin","volume":"360","author":"Jonkman","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.12.003_bb0700","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/jid.2011.477","article-title":"Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations","volume":"132","author":"Pasmooij","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0705","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2009.09118.x","article-title":"Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy","volume":"161","author":"Gostynski","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0710","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaad.2013.08.052","article-title":"Successful therapeutic transplantation of revertant skin in epidermolysis bullosa","volume":"70","author":"Gostynski","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2017.12.003_bb0715","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009342","article-title":"Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa","volume":"6","author":"Umegaki-Arao","year":"2014","journal-title":"Sci. Transl. Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1730306X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1730306X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:47:46Z","timestamp":1759207666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X1730306X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":144,"alternative-id":["S0169409X1730306X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2017.12.003","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional therapies for cutaneous wound repair in epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}